Pharsight

Narcan is owned by Emergent.

Narcan contains Naloxone Hydrochloride.

Narcan has a total of 8 drug patents out of which 0 drug patents have expired.

Narcan was authorised for market use on 18 November, 2015.

Narcan is available in spray, metered;nasal dosage forms.

Narcan can be used as use of naloxone hydrochloride for emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression..

The generics of Narcan are possible to be released after 16 March, 2035.

Patent	Proceeding Filing Date	Status	Respondent	Petitioner
US9211253	February, 2019	Terminated-Denied	Opiant Pharmaceuticals, Inc.	Nalox-1 Pharmaceuticals, LLC
US9629965	February, 2019	FWD Entered	Opiant Pharmaceuticals, Inc.	Nalox-1 Pharmaceuticals, LLC
US9468747	February, 2019	Terminated-Denied	Opiant Pharmaceuticals, Inc.	Nalox-1 Pharmaceuticals, LLC
US9211253	February, 2019	FWD Entered	Opiant Pharmaceuticals, Inc.	Nalox-1 Pharmaceuticals, LLC
US9468747	February, 2019	FWD Entered	Opiant Pharmaceuticals, Inc.	Nalox-1 Pharmaceuticals, LLC
US9775838	February, 2019	Terminated-Denied	Opiant Pharmaceuticals, Inc.	Nalox-1 Pharmaceuticals, LLC
US9561177	February, 2019	Terminated-Denied	Opiant Pharmaceuticals, Inc.	Nalox-1 Pharmaceuticals, LLC
US9629965	February, 2019	Terminated-Denied	Opiant Pharmaceuticals, Inc.	Nalox-1 Pharmaceuticals, LLC

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9629965	EMERGENT	Nasal drug products and methods of their use	Mar, 2035 (11 years from now)
US10085937	EMERGENT	Nasal drug products and methods of their use	Mar, 2035 (11 years from now)
US9480644	EMERGENT	Nasal drug products and methods of their use	Mar, 2035 (11 years from now)
US9775838	EMERGENT	Nasal drug products and methods of their use	Mar, 2035 (11 years from now)
US9561177	EMERGENT	Nasal drug products and methods of their use	Mar, 2035 (11 years from now)
US9707226	EMERGENT	Nasal drug products and methods of their use	Mar, 2035 (11 years from now)
US9468747	EMERGENT	Nasal drug products and methods of their use	Mar, 2035 (11 years from now)
US9211253	EMERGENT	Nasal drug products and methods of their use	Mar, 2035 (11 years from now)

Do you want to check out NARCAN patents from before 2022?

Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 18 November, 2015

Treatment: Use of naloxone hydrochloride for emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.

Dosage: SPRAY, METERED;NASAL